High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$182K
$182,518
Total Sells (Filtered)
$1.4M
$1,434,855
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
| ZVRA |
ZEVRA THERAPEUTICS, INC.
|
Director
Other
|
2026-03-24 | $386,512x2 | M | Form 4 |
| ZVRA |
ZEVRA THERAPEUTICS, INC.
|
CEO
10b5-1 Sell
|
2026-02-09 | $125,186 | S | Form 4 |
|
ZVRA
S
ZEVRA THERAPEUTICS, INC.
Sangiovanni Timothy J.
• Officer • SVP, Finance & Corp Controller
10b5-1 Sell
2026-02-03
$27,548
|
||||||
| ZVRA |
ZEVRA THERAPEUTICS, INC.
|
Officer • SVP, Finance & Corp Controller
10b5-1 Sell
|
2026-02-03 | $27,548 | S | Form 4 |
|
ZVRA
S
ZEVRA THERAPEUTICS, INC.
Schafer Joshua
• Officer • CCO
10b5-1 SellΔOwn -14.4%
2026-02-03
$96,500
|
||||||
| ZVRA |
ZEVRA THERAPEUTICS, INC.
|
Officer • CCO
10b5-1 SellΔOwn -14.4%
|
2026-02-03 | $96,500 | S | Form 4 |
| ZVRA |
ZEVRA THERAPEUTICS, INC.
|
CEO
10b5-1 SellΔOwn -20.0%
|
2026-02-02 | $853,425 | S | Form 4 |
|
ZVRA
S
ZEVRA THERAPEUTICS, INC.
Quartel Adrian W
• Officer • Chief Medical Officer
10b5-1 SellΔOwn -31.8%
2026-01-30
$40,036
|
||||||
| ZVRA |
ZEVRA THERAPEUTICS, INC.
|
Officer • Chief Medical Officer
10b5-1 SellΔOwn -31.8%
|
2026-01-30 | $40,036 | S | Form 4 |
|
ZVRA
S
ZEVRA THERAPEUTICS, INC.
Sangiovanni Timothy J.
• Officer • SVP, Finance & Corp Controller
10b5-1 Sell
2026-01-30
$15,442
|
||||||
| ZVRA |
ZEVRA THERAPEUTICS, INC.
|
Officer • SVP, Finance & Corp Controller
10b5-1 Sell
|
2026-01-30 | $15,442 | S | Form 4 |
| ZVRA |
ZEVRA THERAPEUTICS, INC.
|
Officer • CCO
10b5-1 Sell
|
2026-01-30 | $29,800 | S | Form 4 |
|
ZVRA
S
ZEVRA THERAPEUTICS, INC.
Thompson Rahsaan
• Officer • Chief Legal & Compliance
10b5-1 Sell
2026-01-30
$36,010
|
||||||
| ZVRA |
ZEVRA THERAPEUTICS, INC.
|
Officer • Chief Legal & Compliance
10b5-1 Sell
|
2026-01-30 | $36,010 | S | Form 4 |
| ZVRA |
ZEVRA THERAPEUTICS, INC.
|
CEO
10b5-1 Sell
|
2025-10-10 | $210,908 | S | Form 4 |
|
ZVRA
P
ZEVRA THERAPEUTICS, INC.
FAVORITO TAMARA A
• Director
Discretionary BuyΔOwn +441.6%
2025-09-12
$24,718
|
||||||
| ZVRA |
ZEVRA THERAPEUTICS, INC.
|
Director
Discretionary BuyΔOwn +441.6%
|
2025-09-12 | $24,718 | P | Form 4 |
| ZVRA |
ZEVRA THERAPEUTICS, INC.
|
Director
Discretionary Buy
|
2025-09-12 | $157,800 | P | Form 4 |